Novavax (NVAX) Says FDA Requested Additional Clinical Data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500 set to open near record highs as Treasury yields cool, oil slips
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 13.18 +0.62 (4.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.56 | 52 Week High | $9.23 | |||
| Open | $12.35 | 52 Week Low | $1.16 | |||
| Day High | $13.33 | P/E | N/A | |||
| Day Low | $12.06 | EPS | $-0.30 | |||
| Volume | 3,473,049 | |||||
